Series D raises $25mm for Zeltiq
Executive Summary
Zeltiq (developing the first non-invasive procedure for fat reduction) raised $25mm in its Series D financing led by first-time investor Aisling Capital, which adds a board member. Returning shareholders Advanced Technology Ventures, Frazier Healthcare Ventures, and Venrock also participated.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice